Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for bleeding reduction during endoscopic sinus surgery
PACTR202512570526462Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dexmedetomidine in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Assiut University. Primary endpoint: Total blood loss. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on PACTR202512570526462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512570526462.